Article

Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp.

Eskitis Institute, Griffith University, Brisbane, QLD 4111, Australia.
Journal of Medicinal Chemistry (Impact Factor: 5.61). 06/2012; 55(12):5851-8. DOI:10.1021/jm3002795
Source: PubMed

ABSTRACT A new bispyrroloiminoquinone alkaloid, tsitsikammamine C (1), displayed potent in vitro antimalarial activity with IC(50) values of 13 and 18 nM against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) Plasmodium falciparum, respectively. Tsitsikammamine C (1) displayed selectivity indices of >200 against HEK293 cells and inhibited both ring and trophozoite stages of the malaria parasite life cycle. Previously reported compounds makaluvamines J (2), G (3), L (4), K (5) and damirones A (6) and B (7) were also isolated from the same marine sponge (Zyzzya sp.). Compounds 2-4 displayed potent growth inhibitory activity (IC(50) < 100 nM) against both P. falciparum lines and only moderate cytotoxicity against HEK293 cells (IC(50) = 1-4 μM). Makaluvamine G (3) was not toxic to mice and suppressed parasite growth in P. berghei infected mice following subcutaneous administration at 8 mg kg(-1) day(-1).

0 0
 · 
0 Bookmarks
 · 
82 Views
  • [show abstract] [hide abstract]
    ABSTRACT: In the period from January 1981 to December 2010, 1068 small-molecule new chemical entities (NCEs) were introduced, of which ca. 34% are either a natural product or a close analogue. While this metric reflects the impact natural products have played in delivering new chemical starting points (leads) for the pharmaceutical industry, it does not capture the decline this approach has suffered over the last 20 years as the high-throughput screening (HTS) of pure compound libraries has become more popular. An impediment to natural-product drug discovery in the HTS paradigm is the lack of a clear strategy that enables front-loading of an extract or fraction's chemical constituents so that they are compliant with lead- and drug-like chemical space. To address this imbalance, an approach based on lipophilicity, as measured by clog P has been developed that, together with advances being made in isolation and structural elucidation, can afford natural product leads in timelines compatible with pure compound screening.
    Chemistry & Biodiversity 04/2013; 10(4):524-37. · 1.81 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: This digest covers some of the most relevant progress in malaria drug discovery published between 2010 and 2012. There is an urgent need to develop new antimalarial drugs. Such drugs can target the blood stage of the disease to alleviate the symptoms, the liver stage to prevent relapses, and the transmission stage to protect other humans. The pipeline for the blood stage is becoming robust, but this should not be a source of complacency, as the current therapies set a high standard. Drug discovery efforts directed towards the liver and transmission stages are in their infancy but are receiving increasing attention as targeting these stages could be instrumental in eradicating malaria.
    Bioorganic & medicinal chemistry letters 03/2013; · 2.65 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: In the last decades researchers of natural products chemistry focused their research in a wide variety of bioactive compounds from marine species. Marine sponges (Porifera) have been ranked very high in the priority of natural product research because the discovery of a wide range of bioactive chemical components and secondary metabolites with potential pharmaceutical applications gave promising results. These discoveries have attracted the attention of pharmaceutical chemistry experts, cell biologists, chemists of natural products and medical practitioners. Since the 1950s, when a number of the first publications appeared in the scientific literature, some bioactive natural chemicals from marine sponges gave successful examples of pharmaceuticals. Initial experimental results suggest that sponges have the potential to provide future drugs against important diseases, such as cancer, a range of viral diseases, malaria, and inflammations. At the same time scientists studied the molecular mode of action of most sponge-derived metabolites and their mechanism of action were elucidated for their therapeutic potential in a variety of diseases. This review aims at describing some of the most highly cited reviews of the last decade on sponge-derived bioactive compounds and the most promising substances extracted and isolated from marine sponges for pharmaceutical applications. The review is covering mainly new developments of the last five years in the field of marine sponge metabolite research and important findings for bioactive compounds from in vitro, in vivo and clinical studies for therapeutic drug applications.
    Natural Products Chemistry & Research. 10/2013; 1(3).